Katherine M Bell-McGuinn Selected Research

Katherine M Bell-McGuinn Research Topics

Disease

12	Neoplasms (Cancer) 10/2023 - 08/2007
8	Carcinoma (Carcinomatosis) 01/2022 - 11/2009
7	Ovarian Neoplasms (Ovarian Cancer) 01/2017 - 07/2010
3	Ovarian Epithelial Carcinoma 01/2021 - 11/2010
3	Disease Progression 11/2017 - 02/2016
3	Nausea 02/2016 - 07/2010
2	Breast Neoplasms (Breast Cancer) 01/2021 - 12/2011
2	Fatigue 01/2015 - 07/2010
1	Multiple Myeloma 10/2023
1	B-Cell Lymphoma (Lymphoma, B Cell) 10/2023
1	Embolism (Embolus) 12/2021
1	Febrile Neutropenia 01/2020
1	Fallopian Tube Neoplasms 01/2020
1	Neutropenia 01/2020
1	Sepsis (Septicemia) 11/2017
1	Constipation 02/2016
1	Diarrhea 02/2016
1	Abdominal Pain (Pain, Abdominal) 02/2016
1	Asthenia 02/2016
1	Stomatitis 01/2015
1	Vomiting 01/2015
1	Inflammation (Inflammations) 01/2015
1	Hyperglycemia 01/2015
1	Hypertension (High Blood Pressure) 12/2011
1	Neoplasm Metastasis (Metastasis) 12/2011
1	Ascites 05/2011
1	Carcinogenesis 08/2007

Drug/Important Bio-Agent (IBA)

10	PlatinumIBA 01/2022 - 11/2010
4	RamucirumabIBA 01/2022 - 11/2017
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 12/2011
3	Monoclonal AntibodiesIBA 01/2022 - 11/2010
3	Bevacizumab (Avastin)FDA Link 01/2021 - 12/2011
3	veliparibIBA 01/2021 - 01/2020
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2017 - 07/2010
2	Immunoglobulin G (IgG)IBA 12/2021 - 01/2020
2	Docetaxel (Taxotere)FDA Link 01/2020 - 11/2017
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2020 - 11/2017
2	Cisplatin (Platino)FDA LinkGeneric 06/2012 - 12/2011
2	olaparibIBA 02/2012 - 07/2010
2	CathepsinsIBA 12/2011 - 08/2007
2	Peptide Hydrolases (Proteases)FDA Link 12/2011 - 08/2007
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2011 - 08/2007
1	venetoclaxIBA 10/2023
1	Proteins (Proteins, Gene)FDA Link 10/2023
1	TroponinIBA 10/2023
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Maytansine (Maitansine)IBA 12/2021
1	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 12/2021
1	Immunoconjugates (Immunoconjugate)IBA 12/2021
1	LY3076226IBA 12/2021
1	Carboplatin (JM8)FDA LinkGeneric 01/2021
1	Blood Glucose (Blood Sugar)IBA 12/2018
1	Insulin (Novolin)FDA Link 12/2018
1	GSK2141795IBA 12/2018
1	Antineoplastic Agents (Antineoplastics)IBA 01/2017
1	VTX-2337IBA 01/2017
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2017
1	1-dodecylpyridoxal (PLD)IBA 01/2017
1	rucaparibIBA 01/2017
1	Hemoglobins (Hemoglobin)IBA 02/2016
1	iniparibIBA 02/2016
1	taxaneIBA 02/2016
1	Protein Isoforms (Isoforms)IBA 01/2015
1	gedatolisibIBA 01/2015
1	liposomal doxorubicin (Doxil)FDA Link 02/2012
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2011
1	Etoposide (VP 16)FDA LinkGeneric 12/2011
1	volociximabIBA 05/2011
1	IntegrinsIBA 05/2011
1	farletuzumabIBA 11/2010
1	Folate Receptor 1IBA 11/2010
1	Folic Acid (Vitamin M)FDA LinkGeneric 11/2010
1	Cysteine (L-Cysteine)FDA Link 08/2007
1	PapainIBA 08/2007
1	JPM 565IBA 08/2007

Therapy/Procedure

11	Therapeutics 10/2023 - 08/2007
11	Drug Therapy (Chemotherapy) 01/2022 - 08/2007
1	Immunotherapy 01/2017
1	Cytoreduction Surgical Procedures 11/2009